-
2
-
-
5044239523
-
Sickle-cell disease
-
Stuart MJ, Nagel RL. Sickle-cell disease. Lancet. 2004;364(9442):1343-1360.
-
(2004)
Lancet
, vol.364
, Issue.9442
, pp. 1343-1360
-
-
Stuart, M.J.1
Nagel, R.L.2
-
3
-
-
0023859033
-
Levels of fetal hemoglobin necessary for treatment of sickle cell disease
-
Noguchi CT, Rodgers GP, Serjeant G, Schechter AN. Levels of fetal hemoglobin necessary for treatment of sickle cell disease. N Engl J Med. 1988;318(2):96-99.
-
(1988)
N Engl J Med
, vol.318
, Issue.2
, pp. 96-99
-
-
Noguchi, C.T.1
Rodgers, G.P.2
Serjeant, G.3
Schechter, A.N.4
-
4
-
-
0033536288
-
The beta-thalassemias
-
Olivieri NF. The beta-thalassemias. N Engl J Med. 1999;341(2):99-109.
-
(1999)
N Engl J Med
, vol.341
, Issue.2
, pp. 99-109
-
-
Olivieri, N.F.1
-
5
-
-
0022354852
-
Stimulation of F-cell production in patients with sickle-cell anemia treated with cytarabine or hydroxyurea
-
Veith R, Galanello R, Papayannopoulou T, Stamatoyannopoulos G. Stimulation of F-cell production in patients with sickle-cell anemia treated with cytarabine or hydroxyurea. N Engl J Med. 1985;313(25):1571-1575.
-
(1985)
N Engl J Med
, vol.313
, Issue.25
, pp. 1571-1575
-
-
Veith, R.1
Galanello, R.2
Papayannopoulou, T.3
Stamatoyannopoulos, G.4
-
6
-
-
84862254136
-
Hydroxyurea for the treatment of sickle cell disease: Efficacy, barriers, toxicity, and management in children
-
Strouse JJ, Heeney MM. Hydroxyurea for the treatment of sickle cell disease: efficacy, barriers, toxicity, and management in children. Pediatr Blood Cancer. 2012;59(2):365-371.
-
(2012)
Pediatr Blood Cancer
, vol.59
, Issue.2
, pp. 365-371
-
-
Strouse, J.J.1
Heeney, M.M.2
-
7
-
-
84878154737
-
Optimizing Hydroxyurea use in children with sickle cell disease: Low dose regimen is effective
-
Sharef SW, Al-Hajri M, Beshlawi I, et al. Optimizing Hydroxyurea use in children with sickle cell disease: low dose regimen is effective. Eur J Haematol. 2013;90(6):519-524.
-
(2013)
Eur J Haematol
, vol.90
, Issue.6
, pp. 519-524
-
-
Sharef, S.W.1
Al-Hajri, M.2
Beshlawi, I.3
-
8
-
-
78650376704
-
Examining the characteristics and beliefs of hydroxyurea users and nonusers among adults with sickle cell disease
-
Haywood C Jr, Beach MC, Bediako S, et al. Examining the characteristics and beliefs of hydroxyurea users and nonusers among adults with sickle cell disease. Am J Hematol. 2011;86(1):85-87.
-
(2011)
Am J Hematol
, vol.86
, Issue.1
, pp. 85-87
-
-
Haywood, C.1
Beach, M.C.2
Bediako, S.3
-
9
-
-
80051815757
-
Monitoring toxicity, impact, and adherence of hydroxyurea in children with sickle cell disease
-
Brandow AM, Panepinto JA. Monitoring toxicity, impact, and adherence of hydroxyurea in children with sickle cell disease. Am J Hematol. 2011;86(9):804-806.
-
(2011)
Am J Hematol
, vol.86
, Issue.9
, pp. 804-806
-
-
Brandow, A.M.1
Panepinto, J.A.2
-
10
-
-
67749114687
-
Improvement in hemolysis and pulmonary arterial systolic pressure in adult patients with sickle cell disease during treatment with hydroxyurea
-
Olnes M, Chi A, Haney C, et al. Improvement in hemolysis and pulmonary arterial systolic pressure in adult patients with sickle cell disease during treatment with hydroxyurea. Am J Hematol. 2009;84(8):530-532.
-
(2009)
Am J Hematol
, vol.84
, Issue.8
, pp. 530-532
-
-
Olnes, M.1
Chi, A.2
Haney, C.3
-
11
-
-
40449130473
-
Clinical effectiveness of decitabine in severe sickle cell disease
-
Saunthararajah Y, Molokie R, Saraf S, et al. Clinical effectiveness of decitabine in severe sickle cell disease. Br J Haematol. 2008;141(1):126-129.
-
(2008)
Br J Haematol
, vol.141
, Issue.1
, pp. 126-129
-
-
Saunthararajah, Y.1
Molokie, R.2
Saraf, S.3
-
12
-
-
0034307656
-
2-Deoxy 5-azacytidine and fetal hemoglobin induction in sickle cell anemia
-
Koshy M, Dorn L, Bressler L, et al. 2-deoxy 5-azacytidine and fetal hemoglobin induction in sickle cell anemia. Blood. 2000;96(7):2379-2384.
-
(2000)
Blood
, vol.96
, Issue.7
, pp. 2379-2384
-
-
Koshy, M.1
Dorn, L.2
Bressler, L.3
-
13
-
-
34548428815
-
Decitabine and sickle cell disease: Molecular therapy for a molecular disease
-
Saunthararajah Y. Decitabine and sickle cell disease: molecular therapy for a molecular disease. Pediatr Hematol Oncol. 2007;24(7):465-468.
-
(2007)
Pediatr Hematol Oncol
, vol.24
, Issue.7
, pp. 465-468
-
-
Saunthararajah, Y.1
-
14
-
-
0036625004
-
Maintenance of elevated fetal hemoglobin levels by decitabine during dose interval treatment of sickle cell anemia
-
DeSimone J, Koshy M, Dorn L, et al. Maintenance of elevated fetal hemoglobin levels by decitabine during dose interval treatment of sickle cell anemia. Blood. 2002;99(11):3905-3908.
-
(2002)
Blood
, vol.99
, Issue.11
, pp. 3905-3908
-
-
DeSimone, J.1
Koshy, M.2
Dorn, L.3
-
15
-
-
0030923438
-
Induction of gamma-globin by histone deacetylase inhibitors
-
McCaffrey PG, Newsome DA, Fibach E, Yoshida M, Su MS. Induction of gamma-globin by histone deacetylase inhibitors. Blood. 1997;90(5):2075-2083.
-
(1997)
Blood
, vol.90
, Issue.5
, pp. 2075-2083
-
-
McCaffrey, P.G.1
Newsome, D.A.2
Fibach, E.3
Yoshida, M.4
Su, M.S.5
-
16
-
-
37549053288
-
Pulsed-dosing with oral sodium phenylbutyrate increases hemoglobin F in a patient with sickle cell anemia
-
Hines P, Dover GJ, Resar LM. Pulsed-dosing with oral sodium phenylbutyrate increases hemoglobin F in a patient with sickle cell anemia. Pediatr Blood Cancer. 2008;50(2):357-359.
-
(2008)
Pediatr Blood Cancer
, vol.50
, Issue.2
, pp. 357-359
-
-
Hines, P.1
Dover, G.J.2
Resar, L.M.3
-
17
-
-
0036899584
-
Induction of fetal hemoglobin synthesis in children with sickle cell anemia on low-dose oral sodium phenylbutyrate therapy
-
Resar LM, Segal JB, Fitzpatric LK, Friedmann A, Brusilow SW, Dover GJ. Induction of fetal hemoglobin synthesis in children with sickle cell anemia on low-dose oral sodium phenylbutyrate therapy. J Pediatr Hematol Oncol. 2002;24(9):737-741.
-
(2002)
J Pediatr Hematol Oncol
, vol.24
, Issue.9
, pp. 737-741
-
-
Resar, L.M.1
Segal, J.B.2
Fitzpatric, L.K.3
Friedmann, A.4
Brusilow, S.W.5
Dover, G.J.6
-
18
-
-
0028303870
-
Induction of fetal hemoglobin production in subjects with sickle cell anemia by oral sodium phenylbutyrate
-
Dover GJ, Brusilow S, Charache S. Induction of fetal hemoglobin production in subjects with sickle cell anemia by oral sodium phenylbutyrate. Blood. 1994;84(1):339-343.
-
(1994)
Blood
, vol.84
, Issue.1
, pp. 339-343
-
-
Dover, G.J.1
Brusilow, S.2
Charache, S.3
-
20
-
-
37049008636
-
DNA damage in blood leukocytes of individuals with sickle cell disease treated with hydroxyurea
-
Friedrisch JR, Prá D, Maluf SW, et al. DNA damage in blood leukocytes of individuals with sickle cell disease treated with hydroxyurea. Mutat Res. 2008;649(1-2):213-220.
-
(2008)
Mutat Res
, vol.649
, Issue.1-2
, pp. 213-220
-
-
Friedrisch, J.R.1
Prá, D.2
Maluf, S.W.3
-
21
-
-
77954934323
-
Assessment of genotoxicity associated with hydroxyurea therapy in children with sickle cell anemia
-
Flanagan JM, Howard TA, Mortier N, et al. Assessment of genotoxicity associated with hydroxyurea therapy in children with sickle cell anemia. Mutat Res. 2010;698(1-2):38-42.
-
(2010)
Mutat Res
, vol.698
, Issue.1-2
, pp. 38-42
-
-
Flanagan, J.M.1
Howard, T.A.2
Mortier, N.3
-
22
-
-
80054794827
-
Hydroxyurea induces de novo copy number variants in human cells
-
Arlt MF, Ozdemir AC, Birkeland SR, Wilson TE, Glover TW. Hydroxyurea induces de novo copy number variants in human cells. Proc Natl Acad Sci USA. 2011;108(42):17360-17365.
-
(2011)
Proc Natl Acad Sci USA
, vol.108
, Issue.42
, pp. 17360-17365
-
-
Arlt, M.F.1
Ozdemir, A.C.2
Birkeland, S.R.3
Wilson, T.E.4
Glover, T.W.5
-
23
-
-
0022568850
-
Hydroxyurea induction of hemoglobin F production in sickle cell disease: Relationship between cytotoxicity and F cell production
-
Dover GJ, Humphries RK, Moore JG, et al. Hydroxyurea induction of hemoglobin F production in sickle cell disease: relationship between cytotoxicity and F cell production. Blood. 1986;67(3):735-738.
-
(1986)
Blood
, vol.67
, Issue.3
, pp. 735-738
-
-
Dover, G.J.1
Humphries, R.K.2
Moore, J.G.3
-
24
-
-
0023130331
-
Hydroxyurea-induced augmentation of fetal hemoglobin production in patients with sickle cell anemia
-
Charache S, Dover GJ, Moyer MA, Moore JW. Hydroxyurea-induced augmentation of fetal hemoglobin production in patients with sickle cell anemia. Blood. 1987;69(1):109-116.
-
(1987)
Blood
, vol.69
, Issue.1
, pp. 109-116
-
-
Charache, S.1
Dover, G.J.2
Moyer, M.A.3
Moore, J.W.4
-
25
-
-
79961145533
-
Nuclear receptors TR2 and TR4 recruit multiple epigenetic transcriptional corepressors that associate specifically with the embryonic β-type globin promoters in differentiated adult erythroid cells
-
Cui S, Kolodziej KE, Obara N, et al. Nuclear receptors TR2 and TR4 recruit multiple epigenetic transcriptional corepressors that associate specifically with the embryonic β-type globin promoters in differentiated adult erythroid cells. Mol Cell Biol. 2011;31(16):3298-3311.
-
(2011)
Mol Cell Biol
, vol.31
, Issue.16
, pp. 3298-3311
-
-
Cui, S.1
Kolodziej, K.E.2
Obara, N.3
-
26
-
-
11144332565
-
Histone demethylation mediated by the nuclear amine oxidase homolog LSD1
-
Shi Y, Lan F, Matson C, et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell. 2004;119(7):941-953.
-
(2004)
Cell
, vol.119
, Issue.7
, pp. 941-953
-
-
Shi, Y.1
Lan, F.2
Matson, C.3
-
27
-
-
35348812522
-
LSD1 and the chemistry of histone demethylation
-
Culhane JC, Cole PA. LSD1 and the chemistry of histone demethylation. Curr Opin Chem Biol. 2007;11(5):561-568.
-
(2007)
Curr Opin Chem Biol
, vol.11
, Issue.5
, pp. 561-568
-
-
Culhane, J.C.1
Cole, P.A.2
-
28
-
-
33745187327
-
Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications
-
Lee MG, Wynder C, Schmidt DM, McCafferty DG, Shiekhattar R. Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications. Chem Biol. 2006;13(6):563-567.
-
(2006)
Chem Biol
, vol.13
, Issue.6
, pp. 563-567
-
-
Lee, M.G.1
Wynder, C.2
Schmidt, D.M.3
McCafferty, D.G.4
Shiekhattar, R.5
-
29
-
-
84864856634
-
Dietary restrictions and drug interactions with monoamine oxidase inhibitors: An update
-
Flockhart DA. Dietary restrictions and drug interactions with monoamine oxidase inhibitors: an update. J Clin Psychiatry. 2012;73(Suppl 1):17-24.
-
(2012)
J Clin Psychiatry
, vol.73
, pp. 17-24
-
-
Flockhart, D.A.1
-
30
-
-
84875230084
-
Lysine-specific demethylase 1 is a therapeutic target for fetal hemoglobin induction
-
Shi L, Cui S, Engel JD, Tanabe O. Lysine-specific demethylase 1 is a therapeutic target for fetal hemoglobin induction. Nat Med. 2013;19(3):291-294.
-
(2013)
Nat Med
, vol.19
, Issue.3
, pp. 291-294
-
-
Shi, L.1
Cui, S.2
Engel, J.D.3
Tanabe, O.4
-
31
-
-
84876239967
-
Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A
-
Xu J, Bauer DE, Kerenyi MA, et al. Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A. Proc Natl Acad Sci USA. 2013;110(16):6518-6523.
-
(2013)
Proc Natl Acad Sci USA
, vol.110
, Issue.16
, pp. 6518-6523
-
-
Xu, J.1
Bauer, D.E.2
Kerenyi, M.A.3
-
32
-
-
84857241874
-
Brain-penetrant LSD1 inhibitors can block memory consolidation
-
Neelamegam R, Ricq EL, Malvaez M, et al. Brain-penetrant LSD1 inhibitors can block memory consolidation. ACS Chem Neurosci. 2012;3(2):120-128.
-
(2012)
ACS Chem Neurosci
, vol.3
, Issue.2
, pp. 120-128
-
-
Neelamegam, R.1
Ricq, E.L.2
Malvaez, M.3
-
33
-
-
33747152507
-
Correction of sickle cell disease by homologous recombination in embryonic stem cells
-
Wu LC, Sun CW, Ryan TM, Pawlik KM, Ren J, Townes TM. Correction of sickle cell disease by homologous recombination in embryonic stem cells. Blood. 2006;108(4):1183-1188.
-
(2006)
Blood
, vol.108
, Issue.4
, pp. 1183-1188
-
-
Wu, L.C.1
Sun, C.W.2
Ryan, T.M.3
Pawlik, K.M.4
Ren, J.5
Townes, T.M.6
-
34
-
-
81755163577
-
Forced TR2/TR4 expression in sickle cell disease mice confers enhanced fetal hemoglobin synthesis and alleviated disease phenotypes
-
Campbell AD, Cui S, Shi L, et al. Forced TR2/TR4 expression in sickle cell disease mice confers enhanced fetal hemoglobin synthesis and alleviated disease phenotypes. Proc Natl Acad Sci USA. 2011;108(46):18808-18813.
-
(2011)
Proc Natl Acad Sci USA
, vol.108
, Issue.46
, pp. 18808-18813
-
-
Campbell, A.D.1
Cui, S.2
Shi, L.3
-
35
-
-
84899814457
-
PGC-1 coactivator activity is required for murine erythropoiesis
-
Cui S, Tanabe O, Lim KC, et al. PGC-1 coactivator activity is required for murine erythropoiesis. Mol Cell Biol. 2014;34(11):1956-1965.
-
(2014)
Mol Cell Biol
, vol.34
, Issue.11
, pp. 1956-1965
-
-
Cui, S.1
Tanabe, O.2
Lim, K.C.3
-
36
-
-
84902189880
-
Elevated sphingosine-1-phosphate promotes sickling and sickle cell disease progression
-
Zhang Y, Berka V, Song A, et al. Elevated sphingosine-1-phosphate promotes sickling and sickle cell disease progression. J Clin Invest. 2014;124(6):2750-2761.
-
(2014)
J Clin Invest
, vol.124
, Issue.6
, pp. 2750-2761
-
-
Zhang, Y.1
Berka, V.2
Song, A.3
-
37
-
-
78651245860
-
Detrimental effects of adenosine signaling in sickle cell disease
-
Zhang Y, Dai Y, Wen J, et al. Detrimental effects of adenosine signaling in sickle cell disease. Nat Med. 2011;17(1):79-86.
-
(2011)
Nat Med
, vol.17
, Issue.1
, pp. 79-86
-
-
Zhang, Y.1
Dai, Y.2
Wen, J.3
-
38
-
-
69849094491
-
A novel human gamma-globin gene vector for genetic correction of sickle cell anemia in a humanized sickle mouse model: Critical determinants for successful correction
-
Perumbeti A, Higashimoto T, Urbinati F, et al. A novel human gamma-globin gene vector for genetic correction of sickle cell anemia in a humanized sickle mouse model: critical determinants for successful correction. Blood. 2009;114(6):1174-1185.
-
(2009)
Blood
, vol.114
, Issue.6
, pp. 1174-1185
-
-
Perumbeti, A.1
Higashimoto, T.2
Urbinati, F.3
-
39
-
-
84905662103
-
Developmental transcriptome analysis of human erythropoiesis
-
Shi L, Lin YH, Sierant MC, et al. Developmental transcriptome analysis of human erythropoiesis. Hum Mol Genet. 2014;23(17):4528-4542.
-
(2014)
Hum Mol Genet
, vol.23
, Issue.17
, pp. 4528-4542
-
-
Shi, L.1
Lin, Y.H.2
Sierant, M.C.3
-
40
-
-
34547477270
-
In vitro erythropoiesis from bone marrow-derived progenitors provides a physiological assay for toxic and mutagenic compounds
-
Shuga J, Zhang J, Samson LD, Lodish HF, Griffith LG. In vitro erythropoiesis from bone marrow-derived progenitors provides a physiological assay for toxic and mutagenic compounds. Proc Natl Acad Sci USA. 2007;104(21):8737-8742.
-
(2007)
Proc Natl Acad Sci USA
, vol.104
, Issue.21
, pp. 8737-8742
-
-
Shuga, J.1
Zhang, J.2
Samson, L.D.3
Lodish, H.F.4
Griffith, L.G.5
-
41
-
-
84937862401
-
Compound loss of function of nuclear receptors Tr2 and Tr4 leads to induction of murine embryonic β-type globin genes
-
Cui S, Tanabe O, Sierant M, et al. Compound loss of function of nuclear receptors Tr2 and Tr4 leads to induction of murine embryonic β-type globin genes. Blood. 2015;125(9):1477-1487.
-
(2015)
Blood
, vol.125
, Issue.9
, pp. 1477-1487
-
-
Cui, S.1
Tanabe, O.2
Sierant, M.3
-
42
-
-
48349108293
-
Genome-wide coactivation analysis of PGC-1alpha identifies BAF60a as a regulator of hepatic lipid metabolism
-
Li S, Liu C, Li N, et al. Genome-wide coactivation analysis of PGC-1alpha identifies BAF60a as a regulator of hepatic lipid metabolism. Cell Metab. 2008;8(2):105-117.
-
(2008)
Cell Metab
, vol.8
, Issue.2
, pp. 105-117
-
-
Li, S.1
Liu, C.2
Li, N.3
-
43
-
-
78650419600
-
P-selectin-mediated platelet-neutrophil aggregate formation activates neutrophils in mouse and human sickle cell disease
-
Polanowska-Grabowska R, Wallace K, Field JJ, et al. P-selectin-mediated platelet-neutrophil aggregate formation activates neutrophils in mouse and human sickle cell disease. Arterioscler Thromb Vasc Biol. 2010;30(12):2392-2399.
-
(2010)
Arterioscler Thromb Vasc Biol
, vol.30
, Issue.12
, pp. 2392-2399
-
-
Polanowska-Grabowska, R.1
Wallace, K.2
Field, J.J.3
-
44
-
-
33947244845
-
PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation
-
Yamane K, Tateishi K, Klose RJ, et al. PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation. Mol Cell. 2007;25(6):801-812.
-
(2007)
Mol Cell
, vol.25
, Issue.6
, pp. 801-812
-
-
Yamane, K.1
Tateishi, K.2
Klose, R.J.3
-
45
-
-
33947302685
-
The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases
-
Iwase S, Lan F, Bayliss P, et al. The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases. Cell. 2007;128(6):1077-1088.
-
(2007)
Cell
, vol.128
, Issue.6
, pp. 1077-1088
-
-
Iwase, S.1
Lan, F.2
Bayliss, P.3
-
46
-
-
34547688895
-
Specificity and mechanism of JMJD2A, a trimethyllysine-specific histone demethylase
-
Couture JF, Collazo E, Ortiz-Tello PA, Brunzelle JS, Trievel RC. Specificity and mechanism of JMJD2A, a trimethyllysine-specific histone demethylase. Nat Struct Mol Biol. 2007;14(8):689-695.
-
(2007)
Nat Struct Mol Biol
, vol.14
, Issue.8
, pp. 689-695
-
-
Couture, J.F.1
Collazo, E.2
Ortiz-Tello, P.A.3
Brunzelle, J.S.4
Trievel, R.C.5
-
47
-
-
84872130436
-
Structural and functional analysis of JMJD2D reveals molecular basis for site-specific demethylation among JMJD2 demethylases
-
Krishnan S, Trievel RC. Structural and functional analysis of JMJD2D reveals molecular basis for site-specific demethylation among JMJD2 demethylases. Structure. 2013;21(1):98-108.
-
(2013)
Structure
, vol.21
, Issue.1
, pp. 98-108
-
-
Krishnan, S.1
Trievel, R.C.2
-
48
-
-
84859176881
-
FAD-dependent lysine-specific demethylase-1 regulates cellular energy expenditure
-
Hino S, Sakamoto A, Nagaoka K, et al. FAD-dependent lysine-specific demethylase-1 regulates cellular energy expenditure. Nat Commun. 2012;3:758.
-
(2012)
Nat Commun
, vol.3
, pp. 758
-
-
Hino, S.1
Sakamoto, A.2
Nagaoka, K.3
-
49
-
-
15044361698
-
The serotonin syndrome
-
Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-1120.
-
(2005)
N Engl J Med
, vol.352
, Issue.11
, pp. 1112-1120
-
-
Boyer, E.W.1
Shannon, M.2
-
50
-
-
81555205756
-
Correction of sickle cell disease in adult mice by interference with fetal hemoglobin silencing
-
Xu J, Peng C, Sankaran VG, et al. Correction of sickle cell disease in adult mice by interference with fetal hemoglobin silencing. Science. 2011;334(6058):993-996.
-
(2011)
Science
, vol.334
, Issue.6058
, pp. 993-996
-
-
Xu, J.1
Peng, C.2
Sankaran, V.G.3
-
51
-
-
79960974473
-
Pomalidomide augments fetal hemoglobin production without the myelosuppressive effects of hydroxyurea in transgenic sickle cell mice
-
Meiler SE, Wade M, Kutlar F, et al. Pomalidomide augments fetal hemoglobin production without the myelosuppressive effects of hydroxyurea in transgenic sickle cell mice. Blood. 2011;118(4):1109-1112.
-
(2011)
Blood
, vol.118
, Issue.4
, pp. 1109-1112
-
-
Meiler, S.E.1
Wade, M.2
Kutlar, F.3
|